Skip to content Skip to sidebar Skip to footer

Nigeria: NAFDAC Issues Safety Alert on Recalled U.S. Multivitamins Over Poisoning Risk

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert warning Nigerians against the use or distribution of certain multivitamin and iron supplements recently recalled in the United States due to serious safety concerns.

In a notice shared via its official X (formerly Twitter) account, NAFDAC identified the affected products under the CINCINNATI (WKRC) label, which were distributed widely across the U.S., including through major retailers such as Walmart and Amazon.

The recall, affecting 60,000 units, was initiated after investigations by the U.S. Consumer Product Safety Commissionrevealed that the supplements were improperly packaged, lacking child-resistant safety caps. This flaw significantly increases the risk of accidental poisoning in children, which could result in severe health outcomes or even death.

Among the recalled products are:

  • Daily Prenatal Multi

  • Ultamins Women’s Multivitamin

  • Ultamins Women’s 50+ Multivitamin

NAFDAC warned that if ingested by children, even a small number of iron tablets could lead to symptoms such as vomiting, abdominal pain, dangerously low blood pressure, or liver damage. In more severe cases, these symptoms could escalate rapidly and become life-threatening.

“Without appropriate child-resistant packaging, these products pose a serious and potentially fatal risk to young children,” the agency stated.

In response, NAFDAC has directed all zonal directors and state coordinators to initiate surveillance and ensure that any of the affected products found in circulation within Nigeria are promptly withdrawn.

Distributors, importers, retailers, and healthcare providers have been urged to exercise heightened caution and to avoid the sale or recommendation of these supplements.

Consumers who may have purchased or encountered these products are advised to immediately discontinue use and report any suspected adverse effects or presence of substandard medicines to NAFDAC through:

NAFDAC reiterated its commitment to protecting public health and urged Nigerians to remain vigilant and report suspicious pharmaceutical products for swift regulatory action.

Leave a Comment